A phase I/IIa study of the mRNA-based cancer immunotherapy CV9201 in patients with stage IIIB/IV non-small cell lung cancer - Sebastian, Martin; Thomas, Michael (Cancer immunology immunotherapy, 2019)
Gesehen am 07.10.2019